(Q37228531)

19 August 2017

1 reference

title

Modulation of growth factor action by the extracellular matrix (English)

1 reference

19 August 2017

0 references

Wolf Oehrl

1

1 reference

PubMed ID

18661330

19 August 2017

George Panayotou

series ordinal

2

1 reference

19 August 2017

1 January 2008

1 reference

Connective Tissue Research

19 August 2017

1 reference

19 August 2017

49

1 reference

19 August 2017

145-148

1 reference

19 August 2017

3

1 reference

Membrane-anchored growth factors.

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Autocrine, paracrine and juxtacrine signaling by EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Novel mechanisms of RTK signal generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Receptor tyrosine kinases: mechanisms of activation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Protein modules and signalling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Regulation of Smad activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Growth factor binding to the pericellular matrix and its importance in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Localization of vascular response to VEGF is not dependent on heparin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Insights into the role of heparan sulphate in fibroblast growth factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Structural and Functional Diversity in the FGf Receptor Multigene Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

The fibroblast growth factor-binding protein FGF-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Cellular signaling by fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Neuregulins: functions, forms, and signaling strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

The EGF receptor family: spearheading a merger of signaling and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Fibrillin-1 regulates the bioavailability of TGFbeta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

Receptor tyrosine kinases as targets for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008200802148629

10.1080/03008200802148629

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18661330